Hyperthermia mediated liposomal drug delivery

References

• Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004; 303: 1818–1822
   PubMed Web of Science ®Google Scholar
• Sharpe M, Easthope SE, Keating GM, Lamb HM. Polyethylene glycol-liposomal doxorubicin: A review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs 2002; 62: 2089–2126
   PubMed Web of Science ®Google Scholar
• Mills JK, Needham D. The materials engineering of temperature-sensitive liposomes. Meth Enzymol 2004; 387: 82–113
   PubMed Web of Science ®Google Scholar
• Hettinga JV, Konings AW, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia—a review. Int J Hyperthermia 1997; 13: 439–457
   PubMed Web of Science ®Google Scholar
• Turcotte S, Averill-Bates DA. Sensitization to the cytotoxicity of melphalan by ethacrynic acid and hyperthermia in drug-sensitive and multidrug-resistant Chinese hamster ovary cells. Radiat Res 2001; 156: 272–282
   PubMed Web of Science ®Google Scholar
• Herman TS, Teicher BA. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation. Int J Hyperthermia 1994; 10: 443–449
   PubMed Web of Science ®Google Scholar
• Vertrees RA, Das GC, Popov VL, Coscio AM, Goodwin TJ, Logrono R, Zwischenberger JB, Boor PJ. Synergistic interaction of hyperthermia and gemcitabine in lung cancer. Cancer Biol Ther 2005; 4(10)1144–1153
   PubMed Web of Science ®Google Scholar
• Herman TS, Sweets CC, White DM, Gerner EW. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. J Natl Cancer Inst 1982; 68: 487–491
   PubMedGoogle Scholar
• Nichols JW, Deamer DW. Catecholamine uptake and concentration by liposomes maintaining pH gradients. Biochim Biophys Acta 1976; 455: 269–271
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D, Gabizon A. Liposomes designed to avoid the reticuloendothelial system. Prog Clin Biol Res 1990; 343: 85–93
   PubMedGoogle Scholar
• Allen TM, Hansen CB, Demenezes DEL. Pharmacokinetics of long-circulating liposomes. Adv Drug Del Rev 1995; 16: 267–284
   Web of Science ®Google Scholar
• Allen C, Dos Santos N, Gallagher R, Chiu GN, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS, Bally MB. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep 2002; 22: 225–250
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 1995; 55: 3752–3756
   PubMed Web of Science ®Google Scholar
• Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, Dewhirst MW. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res 1993; 53: 3765–3770
   PubMed Web of Science ®Google Scholar
• Gabizon AA, Lyass O, Berry GJ, Wildgust M. Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignancies. Cancer Invest 2004; 22: 663–669
   PubMed Web of Science ®Google Scholar
• Krishna R, Webb MS, St Onge G, Mayer LD. Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. J Pharmacol Exp Ther 2001; 298: 1206–1212
   PubMed Web of Science ®Google Scholar
• Allen TM, Newman MS, Woodle MC, Mayhew E, Uster PS. Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes. Int J Cancer 1995; 62: 199–204
   PubMed Web of Science ®Google Scholar
• Bandak S, Goren D, Horowitz A, Tzemach D, Gabizon A. Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anticancer Drugs 1999; 10: 911–920
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, Thrall DE. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000; 60: 6950–6957
   PubMed Web of Science ®Google Scholar
• Needham D, Dewhirst MW. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Del Rev 2001; 53: 285–305
   PubMed Web of Science ®Google Scholar
• Yatvin MB, Muhlensiepen H, Porschen W, Weinstein JN, Feinendegen LE. Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth. Cancer Res 1981; 41: 1602–1607
   PubMed Web of Science ®Google Scholar
• Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15: 345–370
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000; 60: 4440–4445
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
   PubMed Web of Science ®Google Scholar
• Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, Thrall DE. Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000; 6: 3748–3755
   PubMed Web of Science ®Google Scholar
• Gaber MH. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia. J Biochem Mol Biol Biophys 2002; 6: 309–314
   PubMedGoogle Scholar
• Ishida O, Maruyama K, Yanagie H, Eriguchi M, Iwatsuru M. Targeting chemotherapy to solid tumors with long-circulating thermosensitive liposomes and local hyperthermia. Jap J Cancer Res 2000; 91: 118–126
   PubMedGoogle Scholar
• Aoki H, Kakinuma K, Morita K, Kato M, Uzuka T, Igor G, Takahashi H, Tanaka R. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: Evaluation of drug distribution in a rat glioma model. Int J Hyperthermia 2004; 20: 595–605
   PubMed Web of Science ®Google Scholar
• Hosokawa T, Sami M, Kato Y, Hayakawa E. Alteration in the temperature-dependent content release property of thermosensitive liposomes in plasma. Chem Pharm Bull 2003; 51: 1227–1232
   PubMed Web of Science ®Google Scholar
• Ono A, Takeuchi K, Sukenari A, Suzuki T, Adachi I, Ueno M. Reconsideration of drug release from temperature-sensitive liposomes. Biol Pharm Bull 2002; 25: 97–101
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000; 60: 1197–1201
   PubMed Web of Science ®Google Scholar
• Mills JK, Needham D. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta 2005; 1716: 77–96
   PubMed Web of Science ®Google Scholar
• Needham D, Stoicheva N, Zhelev DV. Exchange of monooleoylphosphatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)-lipid. Biophys J 1997; 73: 2615–2629
   PubMed Web of Science ®Google Scholar
• Zhelev DV. Material property characteristics for lipid bilayers containing lysolipid. Biophys J 1998; 75: 321–330
   PubMed Web of Science ®Google Scholar
• Anyarambhatla GR, Needham D. Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: A new temperature-sensitive liposome for use with mild hyperthermia. J Liposome Res 1999; 9: 499–514
   Web of Science ®Google Scholar
• Lindner LH, Hossann M, Teichert N. Alkylphosphocholines enhance the drug release rate of thermosensitive liposomes (Abstract). Society for Thermal Medicine Annual Meeting. Bethesda, MD April 2005
   Google Scholar
• Wells J, Sen A, Hui SW. Localized delivery to CT-26 tumors in mice using thermosensitive liposomes. Int J Pharm 2003; 261: 105–114
   PubMed Web of Science ®Google Scholar
• Chandaroy P, Sen A, Hui SW. Temperature-controlled content release from liposomes encapsulating Pluronic F127. J Control Rel 2001; 76: 27–37
   PubMed Web of Science ®Google Scholar
• Kono K, Henmi A, Yamashita H, Hayashi H, Takagishi T. Improvement of temperature-sensitivity of poly(N-isopropylacrylamide)-modified liposomes. J Control Rel 1999; 59: 63–75
   PubMed Web of Science ®Google Scholar
• Kono K, Takagishi T. Temperature-sensitive liposomes. Methods Enzymol 2004; 387: 73–82
   PubMed Web of Science ®Google Scholar
• Hayashi H, Kono K, Takagishi T. Temperature sensitization of liposomes using copolymers of N-isopropylacrylamide. Bioconj Chem 1999; 10: 412–418
   PubMed Web of Science ®Google Scholar
• Chen Q, Tong S, Dewhirst MW, Yuan F. Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther 2004; 3: 1311–1317
   PubMed Web of Science ®Google Scholar
• Blackwell K, Vujaskovic Z, Liotcheva V, Jones E, Clare E, Shaw H, Marcom P, Ellis M, Hardenbergh P, Blivin J, Samulski T, Prosnitz L, Dewhirst M. A phase I dose escalation study of liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. American Society of Clinical Oncology. Orlando, FL 2002
   Google Scholar
• Viglianti BL, Abraham SA, Michelich CR, Yarmolenko PS, MacFall JR, Bally MB, Dewhirst MW. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery. Magn Reson Med 1153; 51: 1153–1162
   PubMed Web of Science ®Google Scholar